This is a distressed balance sheet wrapped in a statistically cheap valuation. A Forward P/E of 10.6 and Price/Sales of 0.2 scream deep value, but the Altman Z-Score of 0.6 is flashing severe financial distress risk, and the company is currently unprofitable with EPS at -1,648.00 and negative operating margins of -2.60%. The market is not irrational here — it is discounting survival risk. While the Forward P/E suggests a rebound narrative, the combination of negative earnings, weak profitability metrics, and a borderline distress-level Z-score implies this is a high-risk turnaround, not a mispriced compounder.